Two US companies are teaming up to conduct a special experiment in space that could improve cancer treatment on Earth. By growing hematopoietic stem cells in the microgravity environment of the International Space Station, they hope to find better ways to help patients battling blood cancer. The experiment, part of the NG-19 mission, aims to produce larger quantities of stem cells that can be used for transplants. This groundbreaking research could revolutionize healthcare and save countless lives.
Better Ways to Grow Stem Cells
Chemotherapy is a common treatment for cancer, but it can harm healthy cells, which can be life-threatening. To prevent this, doctors can use hematopoietic stem cells from a healthy donor’s bone marrow or blood and transplant them into a patient. These cells can also be obtained from umbilical cord blood donations, which are similar to embryonic stem cells and have a lower risk of complications.
However, growing enough cord blood stem cells for transplantation is a challenge. On Earth, these cells usually develop into specific blood cell types, which is not ideal for patient recovery. That’s where the unique microgravity environment of space comes in.
Sierra Space, BioServe, and their partners are conducting an experiment to see if growing hematopoietic stem cells in space can produce larger quantities of these cells. The researchers have sent stem cell samples from multiple cord blood donors to the International Space Station. These samples will be frozen at different times during the experiment and sent back to Earth for analysis.
Sierra Space CEO Tom Vice believes that if they can successfully mass-produce hematopoietic stem cells in space, it could have a transformative impact on patients and their families. This experiment is just the beginning of what Sierra Space envisions – orbiting microgravity factories that can lead to groundbreaking advancements in healthcare. Microgravity is a technology that has the potential to revolutionize healthcare and create a new Industrial Revolution.
Summary
Sierra Space and BioServe Space Technologies are working together to conduct an important experiment in space that could improve cancer treatment on Earth. By growing hematopoietic stem cells in the microgravity environment of the International Space Station, they hope to produce larger quantities of these cells for transplants. This groundbreaking research has the potential to revolutionize healthcare and save lives. Sierra Space is also developing infrastructure capabilities in low-Earth orbit to support commercial space travel and cellular therapeutic manufacturing. The future looks bright for space exploration and its impact on healthcare.
